Astellas Pharma Inc

Research Equipment Procurement Support

Astellas Pharma Inc. – Procurement Support for Oncology Research Laboratory Operations

Biotech & Pharma Case Study

Vehicle: Direct Commercial Procurement
Platform: Zageno Ordering Portal
Product: VWR® Standard Dry Block Heaters (120V)
Category: Pharmaceutical Research & Development
Timeline: Time-Sensitive Laboratory Procurement
Compliance: Manufacturer warranty verification; spec & compatibility confirmation; audit-ready documentation

Organization

Astellas Pharma Inc. is a global pharmaceutical and biotechnology organization focused on advancing therapies in oncology, immunology, urology, and other specialized therapeutic areas. Its research operations depend on validated laboratory equipment, reliable sourcing practices, and uninterrupted access to critical scientific resources supporting active development programs.

Need

Astellas required multiple VWR® Standard Dry Block Heaters to support expanding oncology research activities and assay preparation workflows. The procurement required validated product compatibility, coordinated sourcing, and rapid deployment to maintain laboratory productivity and support ongoing research milestones.

Verified equipment compatibility with existing laboratory workflows
Coordinated sourcing across multiple fulfillment channels
Procurement support aligned with active oncology research schedules
Documentation and warranty validation for laboratory compliance requirements

Response

WDS coordinated procurement activities through the Zageno Ordering Portal, validating product specifications and managing sourcing requirements across fulfillment partners. Documentation, compatibility verification, and inventory onboarding requirements were addressed to support rapid laboratory deployment.

Verified product specifications and compatibility requirements
Coordinated sourcing and consolidated fulfillment activities
Managed procurement documentation and warranty validation
Supported inventory onboarding and laboratory deployment readiness

Outcome

The equipment was successfully integrated into laboratory workflows, supporting assay preparation activities and ongoing oncology research initiatives. Procurement objectives were achieved without disrupting laboratory schedules or research timelines.

Supported uninterrupted laboratory operations
Enabled timely onboarding of research equipment
Reduced procurement complexity through consolidated sourcing
Maintained continuity for active oncology development programs
The procurement was completed without disruption to active laboratory operations, enabling research personnel to maintain assay preparation schedules and continue oncology development activities without equipment-related delays.